Get only news you are interested in!

18889277244 08000885250 1800626514
banner
All products
Apixaban (Eliquis)
Apixaban (Eliquis)
2.5 mg / 30 tabs
$170.00
2.5 mg / 30 tabs 30 tabs $170.00 Buy
Apixaban (Eliquis)
2.5 mg / 60 tabs
$220.00
2.5 mg / 60 tabs 60 tabs $220.00 Buy
Apixaban (Eliquis)
2.5 mg / 90 tabs
$250.00
2.5 mg / 90 tabs 90 tabs $250.00 Buy
Apixaban (Eliquis)
5 mg / 30 tabs
$180.00
5 mg / 30 tabs 30 tabs $180.00 Buy
Apixaban (Eliquis)
5 mg / 60 tabs
$230.00
5 mg / 60 tabs 60 tabs $230.00 Buy
Apixaban (Eliquis)
5 mg / 90 tabs
$280.00
5 mg / 90 tabs 90 tabs $280.00 Buy

Apixaban (Eliquis) - Anticoagulant Therapy for Clot and Stroke Prevention

Apixaban, marketed under the brand name Eliquis, is a powerful anticoagulant medication used to reduce the risk of stroke and blood clots in patients with atrial fibrillation, deep vein thrombosis (DVT), and other conditions related to abnormal blood clot formation. As a direct oral anticoagulant (DOAC), Apixaban works by inhibiting Factor Xa, a key protein in the blood clotting process, thus helping to prevent dangerous clots from forming.

Full Category Description for Apixaban (Eliquis)

Apixaban (Eliquis) is a widely prescribed anticoagulant that plays a crucial role in reducing the risk of stroke and systemic embolism, particularly in patients with non-valvular atrial fibrillation. Unlike traditional blood thinners, Apixaban works directly on Factor Xa, a protein essential to the clotting process, which allows it to effectively prevent clot formation without needing frequent blood monitoring.

Apixaban is also approved for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). These conditions often result from blood clots that form in the legs and can lead to serious complications if they travel to the lungs or other parts of the body. As a reliable and convenient oral therapy, Apixaban has become a preferred choice among healthcare providers for patients at risk of clotting-related complications, providing both safety and effectiveness in managing clotting risks. Patients using Apixaban should always follow their prescribed dosing schedule and consult healthcare providers regularly to ensure safe and effective outcomes.